TY - JOUR
T1 - Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit
AU - Xiong, Li
AU - Davidsdottir, Sigurros
AU - Reijmer, Yael D.
AU - Shoamanesh, Ashkan
AU - Roongpiboonsopit, Duangnapa
AU - Thanprasertsuk, Sekh
AU - Martinez-Ramirez, Sergi
AU - Charidimou, Andreas
AU - Ayres, Alison M.
AU - Fotiadis, Panagiotis
AU - Gurol, Edip
AU - Blacker, Deborah L.
AU - Greenberg, Steven M.
AU - Viswanathan, Anand
N1 - Publisher Copyright:
© 2016 IOS Press and the authors. All rights reserved.
PY - 2016/4/26
Y1 - 2016/4/26
N2 - Background: Cerebral amyloid angiopathy (CAA) is increasingly recognized as a cause of cognitive impairment in the elderly, but the cognitive profile in patients with the disease has not been well characterized. Objective: To characterize the neuropsychological profile of CAA patients without dementia and to determine the association between cognitive performance in different domains and neuroimaging lesions characteristic of CAA. Methods: Fifty-eight non-demented CAA patients were compared to 138 cognitively normal subjects using a standard neuropsychological test battery. Total brain volume (TBV), white matter hyperintensities, number of lobar cerebral microbleeds, hippocampal volume, and cortical superficial siderosis in all CAA patients were assessed. The association between these neuroimaging markers and neuropsychological performance in different cognitive domains in the CAA group were analyzed. Results: Patients with CAA had significantly worse performance on all individual neuropsychological domains tested, when compared to the cognitive normal group. The cognitive decline of CAA patients was most noticeable in tests for processing speed with a Z score of -1.92±1.56 (mean±SD), then followed by executive function (-0.93±1.01), episodic memory (-0.87±1.29), semantic fluency (-0.73±1.06), and attention (-0.42±0.98). TBV of the CAA patients was correlated with processing speed (β= 0.335, p = 0.03) and executive function (β= 0.394, p = 0.01). Conclusions: Non-demented patients with CAA had cognitive deficits in multiple areas. Lower TBV was related to slower processing speed and worse executive function.
AB - Background: Cerebral amyloid angiopathy (CAA) is increasingly recognized as a cause of cognitive impairment in the elderly, but the cognitive profile in patients with the disease has not been well characterized. Objective: To characterize the neuropsychological profile of CAA patients without dementia and to determine the association between cognitive performance in different domains and neuroimaging lesions characteristic of CAA. Methods: Fifty-eight non-demented CAA patients were compared to 138 cognitively normal subjects using a standard neuropsychological test battery. Total brain volume (TBV), white matter hyperintensities, number of lobar cerebral microbleeds, hippocampal volume, and cortical superficial siderosis in all CAA patients were assessed. The association between these neuroimaging markers and neuropsychological performance in different cognitive domains in the CAA group were analyzed. Results: Patients with CAA had significantly worse performance on all individual neuropsychological domains tested, when compared to the cognitive normal group. The cognitive decline of CAA patients was most noticeable in tests for processing speed with a Z score of -1.92±1.56 (mean±SD), then followed by executive function (-0.93±1.01), episodic memory (-0.87±1.29), semantic fluency (-0.73±1.06), and attention (-0.42±0.98). TBV of the CAA patients was correlated with processing speed (β= 0.335, p = 0.03) and executive function (β= 0.394, p = 0.01). Conclusions: Non-demented patients with CAA had cognitive deficits in multiple areas. Lower TBV was related to slower processing speed and worse executive function.
KW - Brain atrophy
KW - cerebral amyloid angiopathy
KW - cerebral microbleeds
KW - clinical neuropsychology
KW - cognitive impairment
KW - hippocampal atrophy
KW - intracranial hemorrhage
KW - white matter hyperintensities
UR - http://www.scopus.com/inward/record.url?scp=84973129425&partnerID=8YFLogxK
U2 - 10.3233/JAD-150890
DO - 10.3233/JAD-150890
M3 - Article
C2 - 27060947
AN - SCOPUS:84973129425
SN - 1387-2877
VL - 52
SP - 171
EP - 178
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
IS - 1
ER -